The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

John C.S. Breitner

Research output: Contribution to journalReview articlepeer-review

Abstract

Risk factor intervention is a useful strategy for prevention of poorly understood diseases. Fifteen studies have examined the relation of glucocorticoid and nonsteroid antiinflammatory treatments and onset or progression of Alzheimer's disease (AD). Fourteen of these studies suggest that such treatments (especially nonsteroidal agents) prevent or ameliorate symptoms of AD. Abundant circumstantial evidence implicates inflammation in the pathogenesis of AD. Inhibition of cyclooxygenases, the central action of nonsteroidal antiinflammatory drugs (but not a prominent effect of steroids), limits inflammation, but it may also alter neural metabolic pathways, resulting in cell death from excitotoxicity or oxidative stress. Randomized controlled trials are needed to determine whether steroids, nonsteroidal antiinflammatory drugs, or both can prevent or treat the symptoms of AD.

Original languageEnglish (US)
Pages (from-to)401-411
Number of pages11
JournalAnnual review of medicine
Volume47
DOIs
StatePublished - 1996

Keywords

  • Corticosteroids
  • Glucocorticoids
  • Inflammation
  • Nonsteroidal antiinflammatory drugs
  • Prevention
  • Treatment

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease'. Together they form a unique fingerprint.

Cite this